Muscle Invasive Bladder Cancer Consensus

Adjuvant Chemotherapy Bladder-sparing Chemoradiation Enhanced Recovery after Surgery Muscle-invasive Bladder Cancer Neoadjuvant Chemotherapy Radical Cystectomy Transurethral Resection of Bladder Tumor Trimodal Urothelial Carcinoma of Bladder Variant Histology

Muscle-invasive Bladder Cancer Guideline

Delphi Bladder Cancer Consensus Diagnosis Follow-up Treatment

Bladder Cancer Chemotherapy Cystectomy Immune Checkpoint Inhibitors

AUC Appropriate Use Criteria Appropriateness Criteria Bladder Cancer Muscle Invasive Bladder Cancer Nonmuscle Invasive Bladder Cancer Surveillance

Bladder Cancer Management Non-muscle-invasive Bladder Cancer Oncology Risk Factors

Bladder Cancer Disease Management Follow-up Guidelines Muscle Invasive

AUC Appropriate Use Criteria Appropriateness Criteria Bladder Cancer CT MRI Muscle-invasive Bladder Cancer Staging Urothelial Carcinoma

Benign Prostatic Hyperplasia Prostate Cancer Bladder Cancer Meta-Analysis

Humans Smoking/adverse effects/epidemiology *Non-Muscle Invasive Bladder Neoplasms *Urinary Bladder Neoplasms/epidemiology/etiology *Carcinoma Transitional Cell Prognosis Neoplasm Recurrence Local/epidemiology Current smoker Non-muscle-invasive bladder cancer Progression Recurrence Smoking

Bladder-sparing strategy Clinical complete response Localized muscle-invasive bladder cancer Neoadjuvant Systemic treatment

Humans Aged Cystectomy/methods *Urinary Bladder Neoplasms/surgery Urinary Bladder *Urinary Diversion/methods Hospital Mortality Bladder cancer Complications Epidemiology Mortality Radical cystectomy Urinary diversions

Humans *Transurethral Resection of Bladder Neoplasm Recurrence Local/pathology *Urinary Bladder Neoplasms/diagnosis/surgery/pathology Prognosis Urologic Surgical Procedures Cystectomy Bladder cancer Css Os Pfs Rfs Transurethral resection of bladder tumors financial ties to disclose.

Bcg Instillation Intravesical Low dose Non–muscle-invasive bladder cancer

Humans Photosensitizing Agents/therapeutic use Neoplasm Residual Neoplasm Recurrence Local/prevention & control *Photochemotherapy/methods Randomized Controlled Trials as Topic *Urinary Bladder Neoplasms/drug therapy/surgery/diagnosis Aminolevulinic Acid/therapeutic use Cystoscopy/methods Cystoscopy Fluorescent cystoscopy Hexaminolevulinate Meta-analysis Nonmuscle invasive bladder cancer Urinary bladder neoplasms conflicts of interest in the manuscript and during the submission process. This manuscript has not been published and is not under consideration for publication elsewhere.

Humans Mitomycin Gemcitabine Hematuria *Non-Muscle Invasive Bladder Neoplasms Deoxycytidine/therapeutic use Administration Intravesical *Urinary Bladder Neoplasms/drug therapy *Cystitis Chemical cystitis Cistitis química Cáncer de vejiga sin invasión muscular Gemcitabina intravesical Intravesical gemcitabine Intravesical mitomycin Mitomicina intravesical Non-muscle invasive bladder cancer Recurrence rates Tasas de recurrencia

Male Humans *Papillomavirus Infections/complications/epidemiology/prevention & control Human Papillomavirus Viruses Mendelian Randomization Analysis Papillomaviridae/genetics Human papillomavirus 18 *Urinary Bladder Neoplasms/epidemiology/complications HPV prevalence bladder cancer human papillomavirus mendelian randomization meta-analysis

Humans Mitomycin/therapeutic use Antibiotics Antineoplastic BCG Vaccine/therapeutic use *Non-Muscle Invasive Bladder Neoplasms Neoplasm Recurrence Local/drug therapy *Urinary Bladder Neoplasms/pathology Administration Intravesical Neoplasm Invasiveness Bladder cancer Device-assisted Emda Intravesical drug administration Nmibc

detrusor muscle en bloc resection of bladder tumor non-muscle invasive bladder cancer